MEDICINES
Sichuan Neautus shares surge 119% in Hong Kong IPO debut
Sichuan Neautus Traditional Chinese Medicine shares soared in their Hong Kong debut after the company raised HK$262 million through an IPO. Strong retail investor demand, reflected in massive oversubscription, drove the stock sharply higher despite weakness in the broader market.
Delhi air pollution: Health experts warn of health risks as even healthy people report symptoms
Doctors from AIIMS and Apollo Hospitals report that Delhi's severe air pollution causes respiratory issues among healthy individuals. Dr. Vijay Hadda emphasizes that green crackers only partially mitigate harmful emissions from conventional firecrackers. Young people aged 20-50 are also complaining of symptoms, indicating widespread health effects. Continuous exposure to high pollution levels can lead to persistent symptoms appearing within hours.
Over 1,300 anti-cancer drugs to get cheaper
India's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative aims to save around ₹2,500 crore annually for cancer patients. The list includes 1,366 drug brands, with substantial price reductions for several high-cost medications. However, some patented drugs will maintain their prices despite the changes. Patients and medical institutions are directed to display revised prices prominently.
Cancer drug prices revised from today; patients may save Rs 3,540 crore annually
The government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit trade margins and reduce consumer costs for cancer drugs. According to official reports, this measure is expected to save consumers Rs 3,540.38 crore each year.
Morepen Laboratories launches Desloratadine (Rx) generic drug product in US market
Morepen Laboratories has launched its prescription generic product Desloratadine in the United States market. This launch is managed through the company's subsidiary, Morpen Bio. Inc. The product will be available in 100-count and 500-count packs to consumers. Additionally, Morepen has submitted an Abbreviated New Drug Application for Sitagliptin Phosphate Tablets to the US FDA. The submission is currently undergoing regulatory review, which is an important step for their expansion.
Pharma industry steps up API investments to cut import dependence, move up value chain
India's pharmaceutical sector is shifting towards high-value medicines and reducing reliance on imports through local manufacturing. Investments in active pharmaceutical ingredients and advanced therapies are on the rise to meet new healthcare demands. Industry leaders highlight the significance of supply-chain resilience and advancements in manufacturing capabilities. Recent data indicates strong domestic market growth and increasing pharmaceutical exports.
Rich countries benefitted more from COVID-19 vaccine's return on investment than poor ones: Study
COVID-19 vaccines generated economic benefits worth USD 60 to USD 809 for every dollar invested in their development and distribution, a global study of 173 countries has found. However, high-income countries gained more due to earlier access and faster rollouts, while delayed vaccine availability limited benefits in poorer nations.
UPSC Success Stories: He cracked AIIMS at 16, cleared UPSC at 22, and left IAS at 24 to build a nearly ₹2,000 crore startup
At just 16, Roman Saini achieved a remarkable feat by clearing the AIIMS entrance examination, and later, he conquered the UPSC Civil Services Examination. Along with his co-founders, he launched Unacademy, a platform dedicated to democratizing education. What began as a YouTube channel has transformed into a valuable online learning hub, boasting a valuation of ₹1,700 crore to ₹1,897 crore following its acquisition by upGrad.
Who are Dominic Roy and Cooper Bruce? Tulane University students discover new muscle attachment that could reshape hip surgery
In a groundbreaking discovery, Tulane University students Dominic Roy and Cooper Bruce uncovered a new muscle attachment during a cadaver dissection. This pelvic structure holds potential implications for understanding hip pain and surgical procedures. Collaborating with Dr. R Shane Tubbs, they validated their findings through further examinations. This breakthrough could reshape treatment strategies for hip-related ailments, igniting Roy and Bruce's aspirations to enter the medical field.
FDA flags persistent data-integrity lapses, insanitary conditions at Indian drug facilities
The US FDA continues to identify serious data integrity issues in Indian pharmaceutical manufacturing facilities. During inspections, inspectors found discarded documents related to key manufacturing processes, highlighting compliance concerns. To ensure safe medicines, drugmakers are urged to scrutinize their supply chains and monitor suppliers effectively. Additionally, human errors contributed significantly to production incidents, affecting operations and batch release timelines.
Iran lifts Hormuz transit curbs for ships from India, China, Iraq and Qatar, could ease pressure on India’s oil and gas supply
Iran has announced the lifting of transit restrictions for vessels from India, China, Iraq, and Qatar. This decision aims to enhance regional cooperation and facilitate trade, particularly in medicines from India. Iranian officials have noted that American forces do not intercept these ships, showing Tehran's strategic interests.
NPPA updates list of reduced MRP of 1,085 anti-cancer drugs
The National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a previous decrease of prices for 543 anti-cancer drugs announced on October 28. The updated list contains prices based on information submitted by pharmaceutical companies up to November 3. The NPPA will continuously update this list as more manufacturers submit revised prices.
Dhanteras 2026: Why Lord Dhanvantari Is Worshipped Alongside Goddess Lakshmi — The Ayurveda Connection Explained
Dhanteras is a vibrant festival that celebrates prosperity and well-being, honoring Goddess Lakshmi and Lord Dhanvantari. Coinciding with Dhanvantari Jayanti, this day highlights the importance of good health as foundational to success. Festivities include acts of devotion, special prayers, and rituals focused on wealth and wellness. In 2026, Dhanteras will be observed on November 6, just ahead of the grand Diwali celebrations.
Cancer drug prices fell in 2019 too, but mark-ups of up to 700% are back
The government's latest cancer drug price cuts may offer patients some relief, but the impact could be short-lived. An analysis of medicines covered in the 2019 exercise found that mark-ups had risen to as much as 700% by 2026, raising questions about whether one-time price cuts can keep cancer treatment affordable.
Sun Pharma’s specialty portfolio, Organon deal to drive growth
Sun Pharmaceutical achieved notable revenue growth in the September quarter, driven by strong performance in India and specialty medicines. The company anticipates medium-term growth from therapies like Ilumya and ongoing innovative projects. Although profitability was affected by acquisition and litigation costs, the domestic market share increased to 8.6% from last year. R&D investments are expected to rise in the second half of FY27 as development accelerates.
India’s medicine sales grow in double digits for four straight quarters, led by chronic care drugs
Over the past four quarters, India's medicine sales have increased significantly due to rising demand in chronic care segments. The growth rate reached 12% year-on-year in the September quarter, showing a positive trend in the industry. Larger pharmaceutical companies have benefited from the shutdown of many non-compliant smaller units. Budgets were also boosted by a reduction in GST on medicines.
Karnataka govt pauses circular on medicine price disclosure by hospitals
In a significant move, the Karnataka government declared it would not proceed with a disputed circular aimed at mandating hospitals to disclose medicine pricing information. This decision emerged during a High Court review related to the circular's compliance and repercussions. The proposal required hospitals to clearly present procurement costs, MRP, and patient billing in their invoices.
India’s drug pricing policy must balance affordability, medicine availability and pharma industry growth
The Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussion about drug pricing and accessibility. The existing regulatory framework aims to provide affordable medicines while supporting the pharmaceutical industry. Ensuring pricing transparency and targeted interventions can help address excessive margins in the supply chain. The ultimate goal remains to enhance patients' access to quality medicines at reasonable prices.
Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrow
India should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a one-size-fits-all formula - to identify where and how intervention is needed. Meaningful stakeholder consultation must form part of this exercise to help design a framework that is both effective and workable. It can ensure that unjustified margins are addressed while recognising legitimate differences in clinical settings, infrastructure, safety requirements, geographical reach and the cost of delivering quality care.
Load More
